ESR1 and breast cancer: On the other hand, estrogen receptor (ER)-positive breast cancer, primarily comprising luminal subtypes, is generally thought to maintain proficient DNA repair mechanisms, with HR deficiency being a less common feature (Feng et al., 2023).